What is CIRS?

Chronic Inflammatory Response Syndrome (CIRS) is a systemic inflammatory condition triggered by exposure to biotoxins in water-damaged buildings. It affects multiple body systems: respiratory, neurological, musculoskeletal, and immune.

The Role of Mycotoxins

Assessment & Testing

Diagnosis requires a combination of clinical history, visual inspection, and specific laboratory markers. We test for:

• Mycotoxins in urine (multiple mold toxins)
• Inflammatory biomarkers (C3a, C4a, TGF-β)
• MMP-9 and other tissue damage markers
• Environment inspection (moisture, visible mold)

Treatment Approach

Framework overview

Mold is one of the most consistent findings in patients whose chronic illness has resisted conventional explanation — and one of the most consistently missed.

What this driver domain covers

Mold and its biological products — particularly mycotoxins — represent one of the most underrecognized contributors to chronic illness in modern medicine. The patients who arrive at iHeal with mold-driven illness rarely arrive knowing that's what they have. They arrive with symptoms — fatigue, brain fog, joint pain, immune dysregulation, dermatologic findings, gastrointestinal complaints — that have been evaluated through specialty after specialty without a unifying explanation.

The exposure pathways are broader than most patients realize. Mold contamination occurs in two distinct biological contexts: in water-damaged buildings, where toxigenic species produce mycotoxins in indoor air; and in the food supply, where storage and processing conditions allow mycotoxin contamination of grains, nuts, coffee, dried fruit, and other staples. Both exposures matter clinically. Patients can have one, the other, or both contributing to their symptom picture.

This page introduces mold as a category. Deeper clinical content lives on two dedicated condition pages: Water-Damaged Building Molds and Mycotoxins (organized around the HERTSMI-2 framework) and Food-Borne Molds and Mycotoxins (organized around dietary exposure sources and the mycotoxins that contaminate them).

Why mold matters as a driver

Mycotoxins are not abstract concerns. They are biologically active molecules that produce documented effects on multiple organ systems. The IARC has classified aflatoxin B1 as a Group 1 carcinogen. Ochratoxin A is a documented nephrotoxin. Trichothecenes from Stachybotrys produce immune suppression. Gliotoxin from Aspergillus species disrupts immune cell function. The mechanisms by which mycotoxins produce symptoms — mitochondrial disruption, immune dysregulation, neurological effects, mast cell activation — are characterized in peer-reviewed literature.

What's poorly characterized in mainstream medical training is how to recognize chronic, low-level mycotoxin exposure as a clinical entity. Acute mycotoxin poisoning is recognized; chronic accumulated exposure producing multi-system symptoms generally is not. Patients fall through this gap. Their primary care doctors don't ask about water damage history or dietary mycotoxin exposure. Their specialists treat individual symptoms without a unifying framework.

What mold exposure produces clinically

Mold-related illness rarely presents as a single isolated symptom. It presents as a constellation, and the constellation varies depending on the specific molds, mycotoxins, and exposure pattern. Common findings across organ systems include:

Immune dysregulation including frequent infections, slow recovery, autoimmune activation, and mast cell activation patterns. Neurological and cognitive symptoms including persistent brain fog, memory difficulties, mood changes, and sensitivity to multiple environmental stimuli. Gastrointestinal effects including bloating, food sensitivities, altered motility, and gut barrier disruption. Dermatologic findings including unexplained rashes, atopic flares, and reactive skin patterns. Musculoskeletal complaints including joint pain, muscle weakness, and post-exertional fatigue. Hair and skin changes including alopecia patterns. Respiratory symptoms including chronic sinusitis, reactive airways, and recurrent respiratory infections. Systemic inflammation that may show on standard markers (CRP, ESR) but more often shows on expanded inflammatory profiles.

The clinical recognition pattern is the multi-system nature of the presentation combined with an exposure history that hasn't been adequately explored. Patients are often surprised when the question is asked directly: "Has there been any water damage in your home, or any building you've lived or worked in extensively, that wasn't fully remediated?" or "What's your typical exposure to corn, peanuts, tree nuts, coffee, and grains — and where do those foods come from?"

How iHeal evaluates mold exposure

The evaluation of mold-driven illness requires both environmental assessment and biological testing. Environmental assessment considers exposure history, building characteristics, dietary patterns, and clinical pattern. Biological testing — when warranted by the clinical picture — uses specialty laboratories that test for the specific mycotoxins associated with the suspected exposure pattern.

The methodology page (How We Evaluate) discusses testing strategy across categories of clinical questions. The two dedicated condition pages on Food-Borne and Water-Damaged Building molds provide the specific clinical detail on each exposure pattern.

What this means for chronic illness more broadly

Mold exposure rarely operates alone. In iHeal's clinical experience, mold contributes alongside other drivers in the 5M Model — metals, microbes, and the response domains of mast cells and mitochondrial dysfunction. The patient with significant water-damaged building exposure often also has mast cell activation, mitochondrial impairment from the mycotoxin burden, and sometimes gut dysbiosis or chronic infection patterns that emerge as the immune system is occupied with the ongoing biotoxin challenge.

This is why mold is positioned as a driver in the 5M Model — it triggers downstream responses that sustain illness even after exposure ends. Identifying and addressing the mold exposure is foundational. Addressing the downstream responses (mast cell activation, mitochondrial dysfunction, infection reactivation) is what restores function.

Frequently Asked Questions